It will be interesting to hear from Medipharm regarding the additional shares from Tilray considering it appears to be rebounding this morning.
Perfect storm for Labs with the potential of doing quite well on those settlement shares as some analysts have Tilray pegged at a high of $4 and hopefully the drop from $2.39 US allows them to double up.